The anandamide effect on NO/cGMP pathway in human platelets

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 924-932

  Signorello, Maria Grazia ^a   Giacobbe, Enrica ^a   Passalacqua, Mario ^a   Leoncini, Giuliana ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

AKT; Anandamide; eNOS activity; Human platelets; Nitric oxide

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CALCIUM; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MK 2206; NITRIC OXIDE; PROTEIN KINASE INHIBITOR; RIMONABANT; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE LIFESPAN;

ARACHIDONIC ACIDS; BLOOD PLATELETS; CALCIUM; CITRULLINE; CYCLIC GMP; ENZYME ASSAYS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PLATELET AGGREGATION; POLYUNSATURATED ALKAMIDES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 79951798879     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23008     Document Type: Article

References (53)

1. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M. 2002a. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105: 71-78. (Pubitemid 34178311)
2. Anfossi G, Russo I, Massucco P, Mattiello L, Trovati M. 2002b. Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3′,5′-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. Thromb Haemost 87:539-540. (Pubitemid 34232500)
3. Bari M, Battista N, Fezza F, Gasperi V, Maccarrone M. 2006. New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 6:257-268.
4. Barry FA, Gibbins JM. 2002. Protein kinase B is regulated in platelets by the collagen receptor glycoprotein VI. J Biol Chem 277:12874-12878. (Pubitemid 34952653)
5. Bátkai S, Rajesh M, Mukhopadhyay P, Haskó G, Liaudet L, Cravatt BF, Csiszár A, Ungvári Z, Pacher P. 2007. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol 293:H909-918.
6. Boo YC. 2006. Shear stress stimulates phosphorylation of protein kinase A substrate proteins including endothelial nitric oxide synthase in endothelial cells. Exp Mol Med 38:453.
7. Born GVR. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929.
8. Braud S, Bon C, Touqui L, Mounier C. 2000. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. FEBS Lett 471:12-16. (Pubitemid 30173284)
9. Calignano A, La Rana G, Giuffrida A, Piomelli D. 1998. Control of pain initiation by endogenous cannabinoids. Nature 394:277-281. (Pubitemid 28335039)
10. Catani MV, Gasperi V, Evangelista D, Finazzi Agrò A, Avigliano L, Maccarrone M. 2010a. Anandamide extends platelets survival through CB(1)-dependent Akt signaling. Cell Mol Life Sci 67:601-610.
11. Catani MV, Gasperi V, Catanzaro G, Baldassarri S, Bertoni A, Sinigaglia F, Avigliano L, Maccarrone M. 2010b. Human platelets express authentic CB(1) and CB(2) receptors. Curr Neurovasc Res 7:311-318.
12. Cencioni MT, Chiurchiù V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M. 2010. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 14:e8688.
13. Cho MJ, Pestina TI, Steward SA, Lowell CA, Jackson CW, Gartner TK. 2002. Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin. Blood 99:2442-2447. (Pubitemid 34525430)
14. Choi BM, Pae HO, Jang SI, Kim YM, Chung HT. 2002. Nitric oxide as a proapoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 35:116-126. (Pubitemid 35216587)
15. Chowdhury KD, Sen G, Biswas T. 2010. Regulatory role of nitric oxide in the reduced survival of erythrocytes in visceral leishmaniasis. Biochim Biophys Acta 1800:964-976.
16. Di Marzo V. 2008. Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438-455.
17. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
18. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. 1995. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
19. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, Stefano GB. 1999. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 11:189-1193.
20. Fleming I, Schulz C, Fichtlscherer B, Kemp BE, Fisslthaler B, Busse R. 2003. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thromb Haemost 90:863-871. (Pubitemid 37427856)
21. Gómez del Pulgar T, Velasco G, Guzmán M. 2000. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 347:369-373. (Pubitemid 30229383)
22. Hartell NA, Archer HE, Bailey CJ. 2005. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol 69:781-790. (Pubitemid 40248620)
23. Hattori Y, Suzuki M, Hattori S, Kasai K. 2003. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 46:1543-1549. (Pubitemid 37518575)
24. Hu W, Jin R, Zhang J, You T, Peng Z, Ge X, Bronson RT, Halperin JA, Loscalzo J, Qin X. 2010. The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood 116:1613-1622.
25. Kroner C, Eybrechts K, Akkerman JW. 2000. Dual regulation of platelet protein kinase B. J Biol Chem 275:27790-27798.
26. Kunos G, Járai Z, Bátkai S, Goparaju SK, Ishac EJ, Liu J, Wang L, Wagner JA. 2000. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 108:159-168.
27. Kunos G, Bátkai S, Offertáler L, Mo F, Liu J, Karcher J, Harvey-White J. 2002. The quest for a vascular endothelial cannabinoid receptor. Chem Phys Lipids 121:45-56.
28. Li Z, Xi X, Gu M, Feil R, Ye RD, Eigenthaler M, Hofmann F, Du X. 2003. A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 112:77-86. (Pubitemid 36106420)
29. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, Kunos G. 2000. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346:835-840. (Pubitemid 30171048)
30. Maccarrone M, Bari M, Menichelli A, Del Principe D, Agrò AF. 1999. Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett 447:277-282. (Pubitemid 29146101)
31. Mackie K, Devane WA, Hille B. 1993. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503. (Pubitemid 23280258)
32. McCabe TJ, Fulton D, Roman LJ, Sessa WC. 2000. Enhanced electron flux and reduced calmodulin dissociation may explain "calciumin-dependent" eNOS activation by phosphorylation. J Biol Chem 75:6123-6128.
33. McCollum L, Howlett AC, Mukhopadhyay S. 2007. Anandamide-mediated CB1/CB2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells. J Pharmacol Exp Ther 321:930-937. (Pubitemid 46762688)
34. McKinney MK, Cravatt BF. 2005. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432. (Pubitemid 40995513)
35. Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z. 1997. Anandamide may mediate sleep induction. Nature 389:25-26. (Pubitemid 27387679)
36. Mòdol T, Natal C, Pérez de Obanos MP, Domingo de Miguel E, Iraburu MJ, López-Zabalza MJ. 2011. Apoptosis of hepatic stellate cells mediated by specific protein nitration. Biochem Pharmacol 81:451-458.
37. Mukhopadhyay S, Chapnick BM, Howlett AC. 2002. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol Heart Circ Physiol 282:H2046-2054.
38. Münzel T, Feil R, Mülsch A, Lohmann SM, Hofmann F, Walter U. 2003. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase. Circulation 108:2172-2183. (Pubitemid 37363031)
39. Nicolay JP, Liebig G, Niemoeller OM, Koka S, Ghashghaeinia M, Wieder T, Haendeler J, Busse R, Lang F. 2008. Inhibition of suicidal erythrocyte death by nitric oxide. Pflugers Arch 456:293-305.
40. O'Sullivan SE, Kendall DA, Randall MD. 2004. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br J Pharmacol 142:435-442. (Pubitemid 38869856)
41. Pertwee RG, Stevenson LA, Griffin G. 1993. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55, 212-2 and anandamide. Br J Pharmacol 110:1483-1490. (Pubitemid 23360982)
42. Pestonjamasp VK, Burstein SH. 1998. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim Biophys Acta 1394:249-260. (Pubitemid 28495659)
43. Radomski MW, Palmer RM, Moncada S. 1990. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193-5197.
44. Randriamboavonjy V, Fleming I. 2005. Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there? Pharmacol Rep 57:59-65.
45. Russo I, Doronzo G, Mattiello L, De Salve A, Trovati M, Anfossi G. 2004. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents. Thromb Res 114:265-273.
46. Salzet M, Breton C, Bisogno T, Di Marzo V. 2000. Comparative biology of the endocannabinoid system possible role in the immune response. Eur J Biochem 267:4917-4927.
47. Signorello MG, Pascale R, Leoncini G. 2003. Transport of L-arginine and nitric oxide formation in human platelets. Eur J Biochem 270:2005-2012. (Pubitemid 36560822)
48. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR. 1994. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227. (Pubitemid 24229631)
49. Stefano GB, Liu Y, Goligorsky MS. 1996. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 271:19238-19242. (Pubitemid 26271589)
50. Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Ishima Y, Waku K. 1996. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur J Biochem 240:53-62.
51. Suzuki T, Nagamatsu C, Kushima T, Miyakoshi R, Tanaka K, Morita H, Sakaue M, Takizawa T. 2010. Apoptosis caused by an inhibitor of NO production in the decidua of rat from mid-gestation. Exp Biol Med (Maywood) 235:455-462.
52. Wagner JA, Varga K, Kunos G. 1998. Cardiovascular actions of cannabinoids and their generation during shock. J Mol Med 76:824-836. (Pubitemid 28518708)
53. Woulfe DS. 2010. Akt signaling in platelets and thrombosis. Expert Rev Hematol 3:81-91.